Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2005-03-22
2005-03-22
Kunz, Gary (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Reexamination Certificate
active
06870030
ABSTRACT:
ASP2 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing ASP2 polypeptides and polynucleotides in the design of protocols for the treatment of Alzheimer's Disease, cancer, and prohormone processing, among others, and diagnostic assays for such conditions.
REFERENCES:
patent: 5292652 (1994-03-01), Dovey et al.
patent: 5744346 (1998-04-01), Chrysler et al.
patent: 5942400 (1999-08-01), Anderson et al.
patent: 6221645 (2001-04-01), Chrysler et al.
patent: 6313268 (2001-11-01), Hook
patent: 6329163 (2001-12-01), Anderson et al.
patent: 20010016324 (2001-08-01), Gurney et al.
patent: 20010018208 (2001-08-01), Gurney et al.
patent: 20010021391 (2001-09-01), Gurney et al.
patent: 0848062 (1998-06-01), None
patent: 0855444 (1998-07-01), None
patent: 1 067 182 (2001-01-01), None
patent: WO 9113904 (1991-09-01), None
patent: WO 9200374 (1992-01-01), None
patent: WO 9203542 (1992-03-01), None
patent: WO 9321526 (1993-10-01), None
patent: WO 9510630 (1995-04-01), None
patent: WO 9513084 (1995-05-01), None
patent: WO 9634097 (1996-10-01), None
patent: WO 9640885 (1996-12-01), None
patent: WO 9748983 (1997-12-01), None
patent: WO 9815828 (1998-04-01), None
patent: WO 9826059 (1998-06-01), None
patent: WO 9934004 (1998-12-01), None
patent: WO 9931236 (1999-06-01), None
patent: WO 9933963 (1999-07-01), None
patent: WO 9946281 (1999-09-01), None
patent: WO 0017369 (2000-03-01), None
patent: WO 0047618 (2000-08-01), None
patent: WO 0053756 (2000-09-01), None
patent: WO 0058479 (2000-10-01), None
patent: WO 0100663 (2001-01-01), None
patent: WO 0100665 (2001-01-01), None
patent: WO 0129563 (2001-04-01), None
patent: WO 0215846 (2002-02-01), None
Mori, et al., “Molecular cloning of a novel mouse aspartic protease-like protein that is expressed abundantly in the kidney”, FEBS Letters, vol. 401, pp. 218-222 (1997).
Miyata, et al., Br. J of Haematology, 1994, 88, 156-65.
GenEmbl Accession No. G24698, human STS Wi-14206, May 31, 1996.
GenEmbl Accession No. MFPERA4, M. fuscata mRNA for pepsinogen A-4 (1991).
O'Toole, et al., Mol. Microbiol., 149(4):691-703 (1994).
Taylor, et al., J. of Bacteriol., 174(21):6800-06 (1992).
Skolnick, et al., Trends in Biotech., 18(1):34-39 (2000).
Vassar, et al., Science 286(5440):735-41, Oct. 22, 1999.
Citron, et al., “Secretases as Targets for the Treatment of Alzheimer's Disease,”Molecular Medicine Today, 6: 392-397 (2000).
Saunders, et al., “BACE Maps to Chromosome 11 and a BACE Homolog, BACE2, Reside in the Obligate Down Syndrome Region of Chromosome 21,”Science, 286: 1255a (1999).
Yan, et al., “Membrane-Anchored Aspartyl Protease with Alzheimer's Disease β-Secretase Activity,”Nature, 402:533-537 (1999).
Hussain, et al., “ASP1 (BACE2) Cleaves the Amyloid Precursor Protein at the Beta-Secretase Site,”Molecular & Cellular Neuroscience, 16(5): 609-619 (2000).
Farzan, et al., “BACE2, a β-Secretase Homolog, Cleaves at the β Site and Within the Amyloid-β Region of the Amyloid-β Precursor Protein,”Proceedings of the National Academy of Sciences, 97(17): 9712-9717 (2000).
Solans, et al., “A New Aspartyl Protease on 21q22.3, BACE2, is Highly Similar to Alzheimer's Amyloid Precursor Protein Beta-Secretase,”Cytogenetics & Cell Genetics, 89(3-4): 177-184(2000).
Bennett, et al., “Expression Analysis of BACE2 in Brain and Peripheral Tissues,”The Journal of Biological Chemistry, 275(27): 20647-20651 (2000).
Acquati, et al., “The Gene Encoding DRAP (BACE2), A Glycosylated Transmembrane Protein of the Aspartic Protease Family, Maps to the Down Critical Region,”FEBS Letters, 468: 59-64 (2000).
NCBI Accession Q9Y5Z0 (Human Asp1). Beta Secretase 2 Precursor (Beta-Site APP-Cleaving Enzyme 2) (Aspartyl Protease 1) (ASP 1) (ASP1) (Membrane-Associated Aspartic Protease 1) (Memapsin-1), Jan. 15, 2002.
NCBI Accession AAF13714. Memapsin 1 [Homo sapiens], Feb. 16, 2000.
NCBI Accession NP 036237. Beta-Site APP-Cleaving Enzyme 2 [Homo Sapiens], Dec. 21, 2003.
NCBI Accession AAF26368. Transmembrane Aspartic Proteinase Asp 1 [Homo sapiens], Jul. 6, 2000.
NCBI Accession AAF17078. Aspartyl Protease 1 [Homo sapiens], Dec. 12, 1999.
NCBI Accession NM 012105. Homo sapiens Beta-Site APP-Cleaving Enzyme 2 (BACE2), mRNA; May 21, 2002.
NCBI Accession AF200192. Homo sapiens Memapsin 1 mRNA, complete eds; Feb. 16, 2000.
NCBI Accession AF204944. Homo sapiens Transmembrane Aspartic Proteinase Asp 1 (BACE2) mRNA, complete eds, Jul. 6, 2000.
NCBI Accession AF178532. Homo sapiens Aspartyl Protease (BACE2) mRNA, complete eds; Sep. 21, 2000.
NCBI Accession AF200342. Homo sapiens Chromosome 21 Aspartyl Protease 1 mRNA, complete eds, Dec. 12, 1999.
Hussain, et al., “Identification of a Novel Aspartic Protease (Asp2) as β-Secretase,”Molecular and Cellular Neuroscience, 14: 419-427 (1999).
Sahasrabudhe, et al., “Enzymatic Generation of the Amino Terminus of the β-Amyloid Peptide,”The Journal of Biological Chemistry, 268(22): 16699-16705 (1993).
Ladror, et al., “Cleavage at the Amino and Carboxyl Termini of Alzheimer's Amyloid-β by Cathepsin D,”The Journal of Biological Chemistry, 269(28): 18422-18428 (1994).
Huber, et al., “cDNA Cloning and Molecular Characterization of Human Brain Metalloprotease MP100: A β-Secretase Condition,”Journal of Neurochemistry, 72(3): 1215-1223 (1999).
Thompson, et al., “Expression and characterization of human β-secretase chandidates metalloendopeptidase MP78 and cathepsin D in βAPP-overexpressing cells,”Molecular Brain Research, 48: 206-214 (1997).
Savage, et al., “Cathepsin G: Localization in Human Cerebral Cortex and Generation of Amyloidogenic Fragments from the β-Amyloid Precursor Protein,”Neuroscience, 60(3): 607-619 (1994).
Nelson, et al., “Identification of a Chymotrypsin-Like Mast Cell Protease in Rat Brain Capable of Generating the N-Terminus of the Alzheimer Amyloid β-Protein,”Journal of Neurochemistry, 61: 567-577 (1993).
McDermott, et al., “Human Brain Peptidase Activity with the Specificity to Generate the N-Terminus of the Alzheimer β-Amyloid Protein from its Precursor,”Biochemistry and Biophysical Research Communications, 185(2): 746-752 (1992).
Ishiura, et al., “Putative N-terminal splitting enzyme of amyloid A4 peptides is the multicatalytic proteinase, ingensin, which is widely distributed in mammalian cells,”FEBS Letters, 257(2): 388-392 (1989).
NCBI Accession: P56817 (Human Asp2). Beta-Secretase Precursor (Beta-Site App Cleaving Enzyme) (Beta-Site Amyloid Precursor Protein Cleaving Enzyme) (Aspartyl Protease 2)(Asp 2)(Asp2)(Membrane-Associated Aspartic Protease2) (Memapsin-2), Jun. 15, 2002.
NCBI Accession XP 006430. Beta-Sitte APP-Cleaving Enzyme (Homo sapiens), Jul. 16, 2001.
NCBI Accession A59090. Aspartic Proteinase (EC 3.4.23.-) BACE Precursor -Human, May 11, 2000.
NCBI Accession NP 036236. Beta-Site APP-Cleaving Enzyme (Homo sapiens), Jan. 15, 2003.
NCBI Accession AAF04142. Beta-Site APP Cleaving Enzyme (Homo sapiens); Oct. 26, 1999.
NCBI Accession AAF13715. Memapsin 2 (Homo sapiens); Feb. 16, 2000.
NCBI Accession 1FKNA. Structures of Beta-Secretase Complexed with Inhibitor; Aug. 9, 2000.
NCBI Accession 1FKNB. Structures of Beta-Secretase Complexed with Inhibitor; Aug. 9, 2000.
NCBI Accession 1FKNC. Structures of Beta-Secretase Complexed with Inhibitor; Aug. 9, 2000.
NCBI Accession 1FKND. Structures of Beta-Secretase Complexed with Inhibitor; Aug. 9, 2000.
NCBI Accession AAF26367. Transmembrane Aspartic Proteinase Asp2 (Homo sapiens), Jan. 19, 2000.
NCBI Accession AAF18982. APP beta-Secretase (Homo sapiens); Dec. 19, 1999.
NCBI Accession AAF 17079. Aspartyl Protease 2 (Homo sapiens), Dec. 12, 1999.
NCBI Accession NT 009334. Homo sapiens Chromosome 11 Working Draft Sequence Segment, complete sequence, Aug. 27, 2001.
NCB
Chapman Conrad G.
Murphy Kay
Powell David J.
Smith Trudi S.
Gimmi Edward R.
Han William T.
Kinzig Charles M.
Kunz Gary
Smithkline Beecham Corporation
LandOfFree
ASP2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with ASP2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and ASP2 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3389396